CENTOGENE Receives Nasdaq Non-Compliance Notice
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 02, 2024 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...
Stay updated with breaking news from Insight Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 02, 2024 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 28, 2024 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...
Aims to Leverage Diversified Data to Accelerate and De-Risk Drug Discovery and Clinical DevelopmentCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 -- CENTOGENE N.V. , the essential...
Aims to Leverage Diversified Data to Accelerate and De-Risk Drug Discovery and Clinical Development...